Anticancer Agents Set to Become Top Therapeutic Category in 2012: IMS Japan

March 28, 2012
IMS Japan recently announced top-line industry data for 2011. Sales of ethical drugs rose 6.9% to ¥9,481.6 billion on an NHI price basis. The lack of an NHI price revision in 2011 probably contributed to this solid increase in sales...read more